27/02/2026
✴️ A NEW CHAPTER FOR GARLAND SURGICAL!
We’re proud to open an exciting new chapter in our journey: our novel, patented hip implant, previously known as MaltaHip, will now be called TriActiv Hip – a name that captures the tri‑axial engineering at the heart of the design, and our vision for enhanced mobility, stability, and durability in today’s active patients.
MaltaHip will always be part of our story. It represents our roots as a University of Malta spin‑out and the foundation that enabled us to secure early funding, clinical interest, and invaluable feedback from partners around the world. But as we ready ourselves for Series A investment, it’s clear our brand must reflect our momentum and ambition.
TriActiv Hip does exactly that. It aligns our identity with our engineering innovation and the clinical outcomes we’re building towards, especially in high‑performance markets where patient mobility matters most.
Alongside this launch, we’re unveiling a refreshed Garland Surgical identity – including a redesigned website – all crafted to express the energy, precision, and purpose behind TriActiv Hip.
What remains unchanged is our mission: to bring this breakthrough technology successfully to market, build robust clinical and commercial evidence, and create lasting value for patients, clinicians, and shareholders alike.
Wishing you all a wonderful weekend and we look forward to sharing our new look with you over the coming weeks....watch this space!
